Nano PRO™ Pen Needles are compatible with the Mounjaro and Zepbound KwikPens1†

Nano PROTM Pen Needles are compatible with widely used insulin and GLP-1 pen injection devices1‡

Lilly
KwikPen (Basaglar, Humalog, Humulin, Mounjaro, Rezvoglar, Zepbound), Tempo Pen
Novo
Nordisk
FlexPen (Novolin, NovoLog), FlexTouch (Fiasp, Levemir, Tresiba), Ozempic, Saxenda, Victoza, Xultophy, NovoPen Echo, Wegovy, Awiqli
Sanofi
SoloStar (Admelog, Apidra, Lantus, Toujeo), Soliqua
Viatris
Semglee
Please refer to the manufacturer's insert that came with the pen device. This list is not all-inclusive of all pen compatibility.
Nano PRO™ Pen Needles are the #1 selling pen needle brand in Canada2
Remember! Not all pen injection devices include pen needles in the box
When leaving the pharmacy, ensure that you have everything you need for your injection device, including your pen needles.
Learn more about Nano PRO™ Pen Needles
Learn more about Nano PRO™ Pen Needles
Nano PRO™ Pen Needles can improve your insulin injection experience3
The combination of innovative features on Nano PRO™ Pen Needles was found by people with diabetes to significantly reduce overall injection pain and make the injection experience easier compared to other pen needles studied.3§
The CONTOURED NEEDLE BASE allows for a more consistent 4mm target injection depth.4¶
In a study, the 4MM NEEDLE WITH A 5-BEVEL TIP provided more comfortable and less painful injections.6§§
  • embecta’s use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between embecta and the owners of these trademarks.
  • Listed brands are owned by third parties.
  • Results from clinical study assessing patient preferences and feedback.
  • To precisely locate injection depth, 1188 injections were administered in swine across a range of clinically relevant injection forces using 20µl of iodinated contrast delivered with Nano PRO™ Pen Needles vs. three 4mm posted-hub pen needles. Measurements were obtained via fluoroscopic imaging. Nano PRO™ Pen Needles more closely achieved the 4mm target injection depth with less variability (p=0.006).
  • A contoured-base pen needle distributes pressure more evenly, reducing the risk of intramuscular injections. While flat-base pen needles are available, currently there is little to no evidence supporting their impact. See reference 5.
  • Patients were aware of the pen needle they were using.
References:
  1. Compatibility Confirmation for Nano PRO™ Pen Needles/1490TH-0004-20. 18 November 2025.
  2. Data on file.
  3. Whooley S, et al. Evaluating the user performance and experience with a reengineered 4 mm x 32G pen needle: a randomized trial with similar length/gauge needles. Diabetes Ther. 2019;10(2):697-712.
  4. Rini C, et al. Evaluating the impact of human factors and pen needle design on insulin pen injection. J Diabetes Sci Technol. 2019;13(3):533-545.
  5. Klonoff DC, et al. Advance Insulin Injection Technique and Education with FITTER Forward Expert Recommendations. Mayo Clin Proc. 2025; 100(4):682-699.
  6. Hirsch L, et al. Impact of a modified needle tip geometry on penetration force as well as acceptability, preference, and perceived pain in subjects with diabetes. J Diabetes Sci Technol. 2012;6(2):328-35.